Medicinal composition for preventing and treating neonatal jaundice and preparation method and application thereof

A technology for neonatal jaundice and composition, applied in the field of pharmaceutical composition for preventing and treating neonatal jaundice and its preparation, and the field of pharmaceutical composition for preventing and treating neonatal jaundice, which can solve potential safety hazards, and there is no newborn drug safety data and clinical experiment data and other problems, to achieve the effect of accelerated self-healing, clear pharmacology, and definite curative effect

Active Publication Date: 2017-05-17
HEFEI HUAFANG PHARMA SCI & TECH
View PDF5 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In Chinese medicine, Yinzhihuang Oral Liquid is used to treat neonatal jaundice, but it is an adult drug, and there is no safety data and clini

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal composition for preventing and treating neonatal jaundice and preparation method and application thereof
  • Medicinal composition for preventing and treating neonatal jaundice and preparation method and application thereof
  • Medicinal composition for preventing and treating neonatal jaundice and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Example 1 Preparation of freeze-dried oral powder

[0035] Weigh 0.25g of geniposide, 4.0g of baicalin, 0.01g of p-hydroxyacetophenone, and 0.35g of chlorogenic acid, dissolve them in 800ml of purified water, adjust the pH value to 7.0 with 10% NaOH, add purified water to 1000ml, and filter , Packed into vials, 1ml per bottle. Move the vials to a vacuum freeze dryer for freeze drying. The temperature drops to -40°C within 1 hour, after 2 hours of heat preservation, the vacuum pump is turned on, the vacuum degree is maintained at 300 Pa, and the temperature is gradually raised to -5°C within 10 hours, the vacuum degree is reduced to 10 Pa, and the temperature is raised to +35°C after maintaining for 2 hours. After maintaining for 3 hours, the vacuum degree does not change, and then it is out of the box, capped, inspected, and packaged. Product moisture is not more than 1%.

Embodiment 2

[0036] Example 2 Preparation of freeze-dried oral powder

[0037] Weigh 0.25g of pregeniposide, 1.7g of baicalin, 0.005g of p-hydroxyacetophenone, and 0.13g of chlorogenic acid, dissolve them in 800ml of purified water, adjust the pH value to 7.0 with 10% NaOH, and then add purified water to 1000ml. Filter and distribute to vials, 1ml per bottle. Move the vials to a vacuum freeze dryer for freeze drying. The temperature drops to -40°C within 1 hour, after 2 hours of heat preservation, the vacuum pump is turned on, the vacuum degree is maintained at 300 Pa, and the temperature is gradually raised to -5°C within 10 hours, the vacuum degree is reduced to 10 Pa, and the temperature is raised to +35°C after maintaining for 2 hours. After maintaining for 3 hours, the vacuum degree does not change, and then it is out of the box, capped, inspected, and packaged. Product moisture is not more than 1%.

Embodiment 3

[0038] Example 3 Preparation of freeze-dried oral powder

[0039] Weigh 0.7g of geniposide, 8.0g of baicalin, 0.02g of p-hydroxyacetophenone, and 0.7g of chlorogenic acid, dissolve them in 800ml of purified water, adjust the pH value to 7.0 with 10% NaOH, add purified water to 1000ml, and filter , Packed into vials, 1ml per bottle. Move the vials to a vacuum freeze dryer for freeze drying. The temperature drops to -40°C within 1 hour, after 2 hours of heat preservation, the vacuum pump is turned on, the vacuum degree is maintained at 300 Pa, and the temperature is gradually raised to -5°C within 10 hours, the vacuum degree is reduced to 10 Pa, and the temperature is raised to +35°C after maintaining for 2 hours. After maintaining for 3 hours, the vacuum degree does not change, and then it is out of the box, capped, inspected, and packaged. Product moisture is not more than 1%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicinal composition for preventing and treating neonatal jaundice and a preparation method and application thereof, and belongs to the field of preparation and application of medicaments for the neonatal jaundice. The invention firstly discloses a medicinal composition for preventing and treating the neonatal jaundice. The medicinal composition is prepared from the following components of geniposide, baicalin, p-hydroxyacetophenone and chlorogenic acid. The invention further discloses a method for preparing the medicinal composition. The method comprises the following steps: weighing the geniposide, the baicalin, the p-hydroxyacetophenone and the chlorogenic acid according to parts by mass; dissolving the geniposide, the baicalin, the p-hydroxyacetophenone and the chlorogenic acid in water; adjusting the pH value to 7.0; filtering; performing split charging; performing freeze drying; pressing a cover; performing inspection; packaging to obtain the medicinal composition. The medicinal composition for preventing and treating the neonatal jaundice can be prepared into freeze-dried oral powder, and has the advantages of convenience in taking, definite curative effect, less adverse reactions, low side effect, high security and the like.

Description

technical field [0001] The invention relates to a pharmaceutical composition for preventing and treating neonatal jaundice, in particular to a pharmaceutical composition for preventing and treating neonatal jaundice, a preparation method and application, and belongs to the field of drug preparation and application for neonatal jaundice. Background technique [0002] In medicine, the jaundice of newborns within 28 days of birth is called neonatal jaundice. Neonatal jaundice refers to the abnormal bilirubin metabolism in the newborn period, which causes the level of bilirubin in the blood to rise, and appears on the skin and mucous membranes. and scleral jaundice. Traditional Chinese medicine generally divides jaundice in children into four types: damp-heat type, heat-toxin type, stasis type, and spleen-dampness type. [0003] Neonatal jaundice is caused by various etiologies. In severe cases, it can endanger the life of children. Currently the most common treatments are bl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/7048A61P1/16A61K31/216
Inventor 汪六一杨贤龙冯栓何勇吴宗好陈开拓
Owner HEFEI HUAFANG PHARMA SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap